Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease

被引：51

作者：

Mizuno, Y

Yanagisawa, N

Kuno, S

Yamamoto, M

Hasegawa, K

Origasa, H

Kowa, H

机构：

[1] Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138421, Japan

[2] Kanto Rosai Hosp, Kawasaki, Kanagawa, Japan

[3] Natl Utano Hosp, Ctr Neurol Dis, Clin Res Sect, Kyoto, Japan

[4] Kagawa Prefectural Cent Hosp, Dept Neurol, Takamatsu, Kagawa, Japan

[5] Sagamihara Natl Hosp, Dept Neurol, Sagamihara, Kanagawa, Japan

[6] Toyama Med & Pharmaceut Univ, Fac Med, Div Biostat, Toyama, Japan

[7] Kitasato Univ, Tokyo, Japan

来源：

MOVEMENT DISORDERS | 2003年 / 18卷 / 10期

关键词：

Parkinson's disease; pramipexole; bromocriptine; levodopa; drug comparison; randomized controlled trial (RCT);

D O I：

10.1002/mds.10508

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

We compared the efficacy and safety of pramipexole (PPX) with placebo in the treatment of advanced Parkinson's disease (PD) as an adjunct to levodopa. A bromocriptine (1311) group was included to enable determination of the noninferiority of PPX relative to 1311 as the standard treatment. (C) 2003 Movement Disorder Society.

引用

页码：1149 / 1156

页数：8

共 50 条

[1] Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease
Guttman, M
Ott, E
Tragner, H
Bedard, PJ
Pourcher, E
Curran, T
Goodridge, A
Guttman, M
Hobson, D
King, D
Martin, WRW
Mendis, T
Rajput, A
Rivest, J
Stoessl, J
Suchowersky, O
Moran, J
Murphy, R
Walsh, B
ONeill, DO
Klemperer, B
Martin, M
Oehlwein, C
Polzer, U
Reichmann, H
Schimek, J
Schlenker, M
Schwartz, A
Meier, D
Traubner, P
Benetin, J
Bomhof, MAM
Hovestadt, A
Vreeling, FW
Wolters, ECMJ
Broddie, HG
Clarke, C
Clough, CJ
Loizou, L
Newman, PK
Pye, IF
[J]. NEUROLOGY, 1997, 49 (04) : 1060 - 1065
[2] A double-blind, placebo-controlled, randomized, multi-center study of pramipexole in advanced Parkinson's disease
Wermuth, L
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 1998, 5 (03) : 235 - 242
[3] Randomized, double-blind study of zonisamide with placebo in advanced Parkinson's disease
Murata, M
Hasegawa, K
Kanazawa, L
[J]. MOVEMENT DISORDERS, 2004, 19 : S198 - S198
[4] Double blind, randomised, placebo controlled study to compare the safety, tolerance and efficacy of pramipexole and bromocriptine in advanced Parkinson's disease
Guttman, M
[J]. NEUROLOGY, 1997, 48 (03) : 32003 - 32003
[5] Pramipexole Ameliorates Depression in Parkinson's Disease: A Randomized Double-Blind Versus Placebo Trial
Barone, Paolo
Poewe, Werner
Massey, Dan
Debieuvre, Catherine Debove
[J]. NEUROLOGY, 2009, 72 (11) : A413 - A413
[6] Efficacy of pramipexole in the treatment of Parkinson's disease:a multi-center,randomized,double-blind,bromocriptine-control trial
温洪波
[J]. China Medical Abstracts (Internal Medicine), 2006, (04) : 228 - 228
[7] Clinical evaluation of pramipexole in advanced Parkinson's disease: Results of a double-blind, placebo-controlled, parallel-group study
Lieberman, A
Ranhosky, A
Korts, D
[J]. NEUROLOGY, 1997, 49 (01) : 162 - 168
[8] Efficacy of double-blind, placebo-controlled pramipexole against depression in Parkinson's disease
Barone, P.
Poewe, W.
Tolosa, E.
Rascol, O.
Massey, D.
Debieuvre, C.
Albrecht, S.
[J]. MOVEMENT DISORDERS, 2009, 24 : S347 - S347
[9] Transdermal rotigotine in advanced Parkinson's disease: a randomized, double-blind, placebo-controlled trial
Nomoto, Masahiro
Mizuno, Yoshikuni
Kondo, Tomoyoshi
Hasegawa, Kazuko
Murata, Miho
Takeuchi, Masahiro
Ikeda, Junji
Tomida, Takayuki
Hattori, Nobutaka
[J]. JOURNAL OF NEUROLOGY, 2014, 261 (10) : 1887 - 1893
[10] Transdermal rotigotine in advanced Parkinson’s disease: a randomized, double-blind, placebo-controlled trial
Masahiro Nomoto
Yoshikuni Mizuno
Tomoyoshi Kondo
Kazuko Hasegawa
Miho Murata
Masahiro Takeuchi
Junji Ikeda
Takayuki Tomida
Nobutaka Hattori
[J]. Journal of Neurology, 2014, 261 : 1887 - 1893

← 1 2 3 4 5 →